Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Levetiracetam NDC 70860-603 by Athenex Pharmaceutical Division, Llc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

lev18 0003 01

lev18 0003 01

lev18 0003 02

lev18 0003 02

This text appears to be the results of a statistical analysis or clinical trial. The percentages provided may relate to changes or differences observed in different groups. The reference to "statistically significant versus placebo" suggests that one group was given a placebo or inactive substance, while the other group received a test treatment. However, without additional context or information, it is not possible to determine what the study was measuring or what the significance of the percentages might be.*

lev18 0003 03

lev18 0003 03

This text appears to be a chart showing percentages of some data points. The data points are labelled on the left-hand side with a range of values from 0% to 35.2%. The chart appears to compare three sets of data, with headings for each set of data labelled "Placebo," "Levetiracetam 1000 mg/day," and "Levetiracetam 2000 mg/day." It is possible that this chart is related to a study on the effectiveness of different doses of Levetiracetam, a medication commonly used to treat epilepsy. However, without additional context, it is difficult to ascertain the exact purpose or findings of the chart.*

lev18 0003 04

lev18 0003 04

lev18 0003 05

lev18 0003 05

lev18 0003 06

lev18 0003 06

NDC 70860-602-41 is a single-dose dual port bag that contains 500mg of Levetiracetam per 100mL of 0.82% Sodium Chloride Injection. This is intended for intravenous infusion over a period of 15 minutes and should not be diluted or used with plastic containers in series connections. Each 100 mL bag also contains water for injection, sodium chloride, glacial acetic acid, and sodium acetate trihydrate. The usual dosage should be observed as per the package insert. Store at 20° to 25°C (68° to 77°F). Made in India for Athenex in Schaumburg, IL 60173, USA.*

lev18 0003 07

lev18 0003 07

Levetiracetam in 0.75% Sodium Chloride Injection is a medication used for intravenous infusion to treat different conditions as directed by a physician. This injection is provided in a dual port bag, with each 100 mL containing 1,000 mg Levetiracetam, 750 mg sodium chloride, and other ingredients, as described in detail. It is suggested not to further dilute the injection and use it once the unit is opened. The standard dosage should be reviewed in the package insert. The injection should be infused over a period of 15 minutes and must not be stored in plastic containers in series connections. It is recommended to store the medication at a temperature of 20° to 25°C.*

lev18 0003 08

lev18 0003 08

This is a medication with NDC code 70860-604-41. It is Levetiracetam in 0.54% Sodium Chloride Injection, with a concentration of 1,500 mg per 100 mL (15 mg per mL). It is for Intravenous Infusion Only to be infused over a period of 15 minutes. Each 100 mL contains Levetiracetam, water for injection, sodium chloride, glacial acetic acid, and sodium acetate trihydrate. The dosage should be as per the package insert, and the medication should not be further diluted before use. Plastic containers in series connections should not be used with it. It is a single-dose dual port bag, made in India, and should be stored at 20° to 25°C (68° to 77°F).*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.